Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) today announced that GPCR Therapeutics…
The debate on MSCs is over; it’s time to promote MSC therapy in practice
TIANJIN, China, Feb. 26, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal…
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
– BRTX-100 is the first and only stem cell product candidate cleared…
NextGenInnov8 Announces Publication of Case Study on Young Innovator Aditya Pachpande, Aligned with India’s Push for STEM and Innovation Education
PUNE, India, Feb. 18, 2025 /PRNewswire/ -- NextGenInnov8, a forward-thinking organization fostering…
Women in Science: Breaking Barriers with HNL Lab Medicine
ALLENTOWN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Women are still vastly…
Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology
CHICAGO, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Stem Health Plus, a leader…
Comcast Premieres “Our Blues Make Us Gold,” A Compelling Documentary Celebrating North Carolina A&T’s Global Impact and Historic Legacy
Documentary showcases the Nation’s Largest Black University’s unique position as both a…
QC Kinetix National Medical Director Dr. Mitchell Sheinkop is the Keynote Speaker at the International Conference on Stem Cells and Regenerative Medicine
Dr. Mitchell Sheinkop CHARLOTTE, N.C., Nov. 11, 2024 (GLOBE NEWSWIRE) -- QC…
KFSHRCs New US Patent Opens New Frontiers for Breast Cancer Treatment
RIYADH, Saudi Arabia, Nov. 10, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist…
DXC Technology Champions STEM Education to Drive Innovation and Diversity
ASHBURN, Va., Nov. 8, 2024 /PRNewswire/ -- DXC Technology (NYSE: DXC), a…